Evogene (EVGN) Assets (2016 - 2026)

Evogene has disclosed Assets across 11 years of filings, most recently posting $13.4 million for Q2 2026.

• In Q2 2026, Assets fell 60.38% year-over-year to $13.4 million; the TTM figure through Jun 2026 stood at $13.4 million (down 60.38% YoY), while the FY2025 annual figure was $20.0 million, down 49.71% from the prior year.
• Assets came in at $13.4 million for Q2 2026 at Evogene, down from $17.9 million in the prior quarter.
• In the past five years, Assets ranged from a high of $56.7 million in Q2 2022 to a low of $13.4 million in Q2 2026.
• Average Assets over 5 years is $37.0 million, with a median of $37.1 million recorded in 2024.
• Year-over-year, Assets slipped 5.86% in 2023 and slumped 60.38% in 2026.
• Over 5 years, Assets stood at $56.1 million in 2022, then dropped by 8.95% to $51.1 million in 2023, then dropped by 21.99% to $39.9 million in 2024, then slumped by 49.71% to $20.0 million in 2025, then slumped by 32.95% to $13.4 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $13.4 million in Q2 2026, $17.9 million in Q1 2026, and $20.0 million in Q4 2025.